Navigation Links
Coronado Biosciences Reports Third Quarter 2011 Financial Results
Date:11/15/2011

d or outstanding.

21,614—Stockholders’ Deficit:Common Stock, $.001 par value, 50,000,000 shares authorized, 7,028,059 shares issued and outstanding as of September 30, 2011; 4,791,102 shares issued and outstanding as of December 31, 2010;

75Additional paid-in capital

5,2064,312Deficit accumulated during the development stage

(49,855)(20,214)Total Stockholders’ Deficit

(44,642)(15,897)Total Liabilities, Convertible Preferred Stock and Stockholders’ Deficit

$26,806$14,939CORONADO BIOSCIENCES, INC. AND SUBSIDIARY(A development stage enterprise)Condensed Consolidated Statements of Operations($ in thousands expect per share amounts)(Unaudited)For the three months endedFor the nine months endedSeptember 30, September 30, 2011

20102011

2010Operating expenses:Research and development

$1,753

$1,822$5,141

$6,341General and administrative

1,778

2603,965

510In-process research and development

—20,706

—Loss from operations

(3,531)

(2,082)(29,812)

(6,851)Interest income

70

24111

32Interest expense, net

(19)

(62)(55)

(1,535)Warrant income

115

—115

—Net loss

($3,365)

($2,120)($29,641)

($8,354)Common Stock dividend to Series A Convertible Preferred Stockholders

—(5,861)

—Net loss attributed to Common Stock

($3,365)

($2,120)($35,502)

($8,354)Basic and diluted net loss per common share

($0.48)

($0.44)($6.02)

($1.92)Weighted average common shares outstanding—basic and diluted

7,028,060

4,791,1025,897,462

4,349,345Contact Information:Investor Relations

Noah D. Beerman, Executive Vice President & Chief Operating Officer
Coronado Biosciences, Inc.
781-238-6619; '/>"/>

SOURCE Coronado Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Coronado Biosciences Appoints Noah D. Beerman as Executive Vice President and Chief Operating Officer
2. Coronado Biosciences to Present at the Rodman & Renshaw Annual Global Investment Conference
3. Coronado Biosciences Files to Become a Public Reporting Company
4. Coronado Biosciences Closes $25.8M in Series C Financing
5. Coronado Biosciences, Inc. Announces Completion of Financings, Management Changes and Development Update
6. Regado Biosciences, Inc. Presents Three Abstracts Pertaining to its Pipeline of Reversible Antithrombotic Agents, Including the Substudy Analyses of its Phase 2b RADAR Trial for REG1, its Lead Product Candidate, at the American Heart Association (AH
7. Signum Biosciences, Inc. Announces Collaborative Agreement with GlaxoSmithKline
8. Neurocrine Biosciences to Present at the 2011 Credit Suisse Annual Health Care Conference
9. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2011 Financial Results
10. Neurocrine Biosciences Receives Second Milestone Payment of $20 Million Under Abbott Collaboration Agreement
11. Regado Biosciences, Inc. to Present at the Sofinnova Japan Biopharma Partnering Conference in Tokyo, Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Medical is very pleased to announce the appointment of Mr. ... Officer.  Mark was promoted from his current role of Chief ... facilities in Massachusetts , Mississippi ... in 2012 with 20+ years of broad-based operations, sales, engineering ...
(Date:1/15/2014)...  According to Millennium Research Group (MRG), the global ... the United States and European transcatheter ... moderately through 2022, with embolization particles representing one ... in drug-eluting beads (DEBs) and radioembolization spheres in ...
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: Global Markets ... -- Focus on End Users ... A drug delivery system is ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
... June 1 DURECT Corporation (Nasdaq: DRRX ) announced today that ... the Jefferies Global Life Sciences Conference on Thursday, June 10 at ... Hotel in New York .   , ...   http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO ) , , , ...
... , June 1 Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ) ... Officer, will present at the Jefferies 2010 Global Life Sciences Conference on ... the Grand Hyatt Hotel in New York, NY . , ... A live webcast of the presentation may be accessed ...
Cached Medicine Technology:DURECT to Present at the Jefferies Global Life Sciences Conference 2
(Date:7/9/2014)... winning is one of the key determinants that makes organized ... mental bonuses ranked near the bottom of 81 determinants of ... fun factors, according to a new study. Despite the common ... the "fun" factor, very little research had been done to ... now. , The results of this study might help researchers ...
(Date:7/9/2014)... School of Medicine at the University of Pennsylvania in ... an $8 million grant from the National Cancer Institute ... (PDT) in patients with malignant pleural mesothelioma, a rare, ... in the lining of the lungs and is caused ... fund a clinical trial and additional studies looking at ...
(Date:7/9/2014)... research into the metabolism of stromal support cells and ... of these cell types in the development of diseases ... conditions and cancer. That was the conclusion of a ... in the leading journal Nature . , Prof. ... wake-up call. The metabolism of cancer cells has been ...
(Date:7/9/2014)... ITHACA, N.Y. Although feelings are personal and ... standard code that objectively represents emotions across different ... study by Cornell University neuroscientist Adam Anderson. , ... within the orbitofrontal cortex, an area of the ... neural code which captures an individual,s subjective feeling," ...
(Date:7/9/2014)... more than watching World Cup highlights, Brian Williams refreshing ... in unfortunate positions on railings. A University of Colorado ... Journal shows that YouTube also allows researchers, journals, ... on topics of skin cancer and prevention. , "No ... future of how we communicate around the world," says ...
Breaking Medicine News(10 mins):Health News:Being a good sport ranks as the top 'fun' factor in study of youth sports 2Health News:Being a good sport ranks as the top 'fun' factor in study of youth sports 3Health News:Penn mesothelioma program receives $8 million NCI grant 2Health News:Wake-up call for more research into cell metabolism 2Health News:Study cracks how the brain processes emotions 2Health News:Study of dermatology on YouTube shows new ways science reaches public 2
... by Dr. Agarwal Hospital:, An eye surgeon / scientist ... wide had thought we were 10 years away from,making DNA, ... the making of DNA and used it on her patients ... attributes the Science of Sri Vidya to this,phenomenal discovery. A ...
... fossil hunter and anatomy professor Kenneth Rose, Ph.D. was displaying ... seminar at the Johns Hopkins University School of Medicine when ... , That unanticipated eureka moment has led researchers at the ... rabbits. The fossil evidence in hand, found in west-central India, ...
... an estimated 10 to 13 percent of the American diet. ... in 2007 was $70.5 billion, with estimates for 2008 rising ... into the United States of imported food and food-related products ... which include ports, border crossings, and postal facilities. ...
... Plans for Growth, LAS VEGAS, March 19 ... members of its executive team presented,at the annual Citi ... on Wednesday, March 19, 2008., In addressing the ... and CEO Stephen Hughes recounted the accomplishments of,2007 and ...
... increase risk and may be early indication, study ... A combination of cholesterol-associated gene variants can increase ... sudden cardiac death, Massachusetts General Hospital researchers report. ... for these gene variants in order to identify ...
... than with freshly stored units, study finds , , ... get transfusions of blood that has been stored for ... get newer blood, a new study shows. , In-hospital ... were higher for those getting older blood, conclude physicians ...
Cached Medicine News:Health News:Science of Sri Vidya Benefits DNA Genesis, Says Dr. Sunita Rana Agarwal 2Health News:Good luck indeed: 53 million-year-old rabbit's foot bones found 2Health News:Smart Balance Presented at Citi Small/Midcap Conference 2Health News:Gene Variants Can Predict Threat of Heart Disease 2Health News:Transfusions of 'Older' Blood Don't Work as Well 2Health News:Transfusions of 'Older' Blood Don't Work as Well 3
Straight shafts with fine pierse type tips. Flat open serrated handle with dull finish....
The Elschnig teeth of this forceps are ideal for grasping sclera during suturing. Delicate tying platform handles the finest suture material. 0.12 mm, 1 x 2 teeth....
Jaws with fine teeth. Serrated handle with polished finish. Jaws: Wide, 4.5 mm. With thumb catch lock....
Straight shafts with heavy Elschnig teeth. Flat serrated handle with slide style lock and polished finished....
Medicine Products: